Lobe Sciences Ltd (LOBE.CX)
0.015
0.00 (0.00%)
CAD |
CNSX |
Nov 11, 16:00
Lobe Sciences EPS Diluted (Quarterly): -0.0027 for May 31, 2024
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| May 31, 2024 | -0.0027 |
| February 29, 2024 | -0.01 |
| November 30, 2023 | -0.01 |
| August 31, 2023 | -0.0174 |
| May 31, 2023 | -0.0027 |
| February 28, 2023 | -0.01 |
| November 30, 2022 | -0.03 |
| August 31, 2022 | -0.0677 |
| May 31, 2022 | -0.30 |
| February 28, 2022 | -0.08 |
| November 30, 2021 | -0.12 |
| August 31, 2021 | -0.4552 |
| May 31, 2021 | 1.92 |
| February 28, 2021 | -0.12 |
| November 30, 2020 | -0.06 |
| August 31, 2020 | -0.30 |
| May 31, 2020 | -0.06 |
| February 29, 2020 | -0.12 |
| November 30, 2019 | -0.06 |
| August 31, 2019 | -0.0848 |
| May 31, 2019 | 0.12 |
| March 31, 2019 | -0.06 |
| December 31, 2018 | -0.1907 |
| September 30, 2018 | -0.0208 |
| June 30, 2018 | -0.0114 |
| Date | Value |
|---|---|
| March 31, 2018 | -0.0171 |
| December 31, 2017 | -0.0759 |
| September 30, 2017 | -0.0118 |
| June 30, 2017 | -0.0208 |
| March 31, 2017 | -0.0126 |
| December 31, 2016 | -0.074 |
| September 30, 2016 | -0.0203 |
| June 30, 2016 | -0.0106 |
| March 31, 2016 | -0.0151 |
| December 31, 2015 | -0.1735 |
| September 30, 2015 | -0.0204 |
| June 30, 2015 | -0.0185 |
| March 31, 2015 | -0.0276 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | -0.0429 |
| June 30, 2014 | -0.0417 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | -0.12 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| September 30, 2012 | -0.12 |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.00 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Quarterly) Range, Past 5 Years
-0.4552
Minimum
Aug 2021
1.92
Maximum
May 2021
0.005
Average
-0.06
Median
Nov 2019
EPS Diluted (Quarterly) Benchmarks
| Biocure Technology Inc | -0.0022 |
| Core One Labs Inc | -0.02 |
| Restart Life Sciences Corp | -0.0031 |
| Nanosphere Health Sciences Inc | -0.0137 |
| Algernon Pharmaceuticals Inc | -0.1975 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.4268M |
| Total Expenses (Quarterly) | 0.6236M |
| Enterprise Value | 4.758M |
| Earnings Yield | -267.2% |
| Normalized Earnings Yield | -266.26 |